Skip to main content
Top
Published in: Rheumatology International 10/2007

01-08-2007 | Original Article

Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?

Authors: Hakan Erdem, Salih Pay, Ugur Musabak, Ismail Simsek, Ayhan Dinc, Aysel Pekel, Ali Sengul

Published in: Rheumatology International | Issue 10/2007

Login to get access

Abstract

In our previous studies, we found higher synovial fluid (SF) levels of angiogenic ELR(+) CXC chemokines such as CXCL1, CXCL5, CXCL6 and CXCL8, which play an important role in neutrophil migration and angiogenesis, and more abundant synovial CXCR2 chemokine receptor expression in patients with rheumatoid arthritis (RA) than those with Behçet’s disease (BD), familial Mediterranean fever and osteoarthritis (OA). As a continuation of our previous studies, we investigated synovial levels of angiostatic non-ELR CXC chemokines (CXCL4, CXCL9 and CXCL10) in patients with RA, BD, spondyloarthritis (SpA), and OA. Seventy (17 RA, 15 BD, 19 SpA, and 19 OA) patients were enrolled in the study. The levels of CXCL4, CXCL9, and CXCL10 were measured by ELISA. The SF levels of CXCL4 in patients with RA were higher than those of the patients with BD, SpA, and OA (P = 0.007, P = 0.022, and P = 0.017, respectively). No difference was found with respect to CXCL4 levels among the BD, SpA, and OA patients. The synovial CXCL9 levels of patients with RA and SpA were found to be higher than those of the patients with OA (P = 0.002 and P = 0.005, respectively), while no statistically significant difference was detected among the other groups. With regard to SF CXCL10 levels, patients with RA had higher levels as compared to patients with OA (P = 0.002), but no significant difference was found among the other groups. CXCL9 correlated with CXCL4 and CXCL10 (P < 0.05 for both) in patients with RA. No correlation was found in other parameters. The angiostatic non-ELR CXC chemokines were expressed in synovial inflammation. We proposed that angiostatic non-ELR CXC chemokines may increase to balance angiogenic ELR (+) CXC chemokines in which increased levels were shown in patients with inflammatory arthritides and CXCL4 may contribute to designate the chronicity of synovitis in patients with RA. In addition, as CXCL-9 and CXCL-10 play crucial role in inflammation characterized by Th1 polarization, we suggested that they may contribute to the commencement and the perpetuation of synovitis seen in these groups of arthritides.
Literature
1.
go back to reference Manzo A, Caporali R, Montecucco C, Pitzalis C (2003) Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in immune/inflammatory response. Clin Exp Rheumatol 21:501–508PubMed Manzo A, Caporali R, Montecucco C, Pitzalis C (2003) Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in immune/inflammatory response. Clin Exp Rheumatol 21:501–508PubMed
2.
go back to reference Vergunst CE, Tak PP (2005) Chemokines: their role in rheumatoid arthritis. Curr Rheumatol Rep 7:382–388PubMedCrossRef Vergunst CE, Tak PP (2005) Chemokines: their role in rheumatoid arthritis. Curr Rheumatol Rep 7:382–388PubMedCrossRef
3.
go back to reference Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP (2005) CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16:593–609PubMedCrossRef Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP (2005) CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16:593–609PubMedCrossRef
4.
go back to reference Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J et al (1995) The functional role of ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348–27357PubMedCrossRef Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J et al (1995) The functional role of ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348–27357PubMedCrossRef
5.
go back to reference Pay S, Erdem H, Serdar M, Dinç A, Şimşek İ, Turan M (2002) Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet’s disease and familial Mediterranean fever? Clin Rheumatol 21:511–515PubMedCrossRef Pay S, Erdem H, Serdar M, Dinç A, Şimşek İ, Turan M (2002) Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behçet’s disease and familial Mediterranean fever? Clin Rheumatol 21:511–515PubMedCrossRef
6.
go back to reference Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A (2005) Synovial Proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet’s disease. Does interleukin-1β play a major role in Behçet’s Synovitis? Rheumatol Int. (Online) Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A (2005) Synovial Proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet’s disease. Does interleukin-1β play a major role in Behçet’s Synovitis? Rheumatol Int. (Online)
7.
go back to reference Erdem H, Pay S, Serdar M, Şimşek İ, Dinç A, Muşabak U, Pekel A, Turan M (2005) Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet’s disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis. Rheumatol Int 26:162–167PubMedCrossRef Erdem H, Pay S, Serdar M, Şimşek İ, Dinç A, Muşabak U, Pekel A, Turan M (2005) Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet’s disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis. Rheumatol Int 26:162–167PubMedCrossRef
8.
go back to reference Pay S, Musabak U, Simsek İ, Pekel A, Erdem H, Dinç A, Şengül A (2005) Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: does persistent or increasing expression of CXCR2 contribute to the chronic inflammation or erosive changes? Annual European Congress on Rheumatology-EULAR 2005, 7–11 June 2005 Pay S, Musabak U, Simsek İ, Pekel A, Erdem H, Dinç A, Şengül A (2005) Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: does persistent or increasing expression of CXCR2 contribute to the chronic inflammation or erosive changes? Annual European Congress on Rheumatology-EULAR 2005, 7–11 June 2005
9.
go back to reference Calabrese LH, Michel BA, Bloch DA (1990) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 33:1108–1113PubMedCrossRef Calabrese LH, Michel BA, Bloch DA (1990) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 33:1108–1113PubMedCrossRef
10.
go back to reference International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080 International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
11.
go back to reference Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRef Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRef
12.
go back to reference Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18:10–12 Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol 18:10–12
13.
go back to reference Rudolph EH, Woods JM (2005) Chemokine expression and regulation of angiogenesis in rheumatoid arthritis. Curr Pharm Des 11:613–631PubMedCrossRef Rudolph EH, Woods JM (2005) Chemokine expression and regulation of angiogenesis in rheumatoid arthritis. Curr Pharm Des 11:613–631PubMedCrossRef
14.
go back to reference Romagnani P, Lasagni L, Anniziato F, Serio M, Romagnani S (2004) CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 25:200–209CrossRef Romagnani P, Lasagni L, Anniziato F, Serio M, Romagnani S (2004) CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 25:200–209CrossRef
15.
go back to reference Rosenkilde MM, Schwartz TW (2004) The chemokine system—a major regulator of angiogenesis in health and disease. APMIS 112:481–495PubMedCrossRef Rosenkilde MM, Schwartz TW (2004) The chemokine system—a major regulator of angiogenesis in health and disease. APMIS 112:481–495PubMedCrossRef
16.
go back to reference Koch AE, Volin MV, Woods JM, Kunkel SL, Connors MA, Harlow LA et al (2001) Regulation of angiogenesis by the CXC chemokines interleukine-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum 44:31–40PubMedCrossRef Koch AE, Volin MV, Woods JM, Kunkel SL, Connors MA, Harlow LA et al (2001) Regulation of angiogenesis by the CXC chemokines interleukine-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum 44:31–40PubMedCrossRef
17.
go back to reference Patel DD, Zachariah JP, Whichard LP (2001) CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 98:39–45PubMedCrossRef Patel DD, Zachariah JP, Whichard LP (2001) CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 98:39–45PubMedCrossRef
18.
go back to reference Strieter RM, Belperio JA, Burdick MD, Keane MP (2005) CXC chemokines in angiogenesis relevant to chronic fibroproliferation. Curr Drug Targets İnflamm Allergy 4:23–26PubMedCrossRef Strieter RM, Belperio JA, Burdick MD, Keane MP (2005) CXC chemokines in angiogenesis relevant to chronic fibroproliferation. Curr Drug Targets İnflamm Allergy 4:23–26PubMedCrossRef
19.
go back to reference Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:1–7CrossRef Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:1–7CrossRef
20.
go back to reference Esche C, Stellato C, Beck LA (2005) Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125:615–628PubMedCrossRef Esche C, Stellato C, Beck LA (2005) Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125:615–628PubMedCrossRef
Metadata
Title
Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?
Authors
Hakan Erdem
Salih Pay
Ugur Musabak
Ismail Simsek
Ayhan Dinc
Aysel Pekel
Ali Sengul
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0317-6

Other articles of this Issue 10/2007

Rheumatology International 10/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.